Labcorp has launched the Thrive 5 Health Test through a collaboration with Thrive Global, the behavior change technology company founded by Arianna Huffington. The test is available through Labcorp’s OnDemand home testing service and is designed to pair health insights with Thrive Global’s behavior modification technology.
The product focuses on five cardiovascular, inflammatory and metabolic health indicators: ApoB for cholesterol-related cardiovascular risk, hs-CRP for inflammation, HbA1c for blood sugar, blood pressure and body mass index. According to Labcorp and Thrive Global, those measures are intended to provide a broader picture of cardiometabolic health than any single measure on its own.
What The Product Includes
After receiving results, patients are sent educational content and are recommended behavioral modifications that Thrive Global calls “Thrive Microsteps.” These are described as small daily actions tied to food, movement, sleep, stress management and connection, with the goal of supporting sustainable behavioral change.
In statements announcing the launch, Huffington said the collaboration is intended to address a gap between receiving health information and knowing what to do with it. Labcorp executive vice president and chief marketing officer Amy Summy said the partnership combines Labcorp’s scientific expertise and nationwide network with Thrive Global’s behavior-change approach so consumers can move from knowing their numbers to understanding what actions they can take.
The Commercial Picture
The test enters a growing class of consumer-facing medtech platforms that combine testing with actionable health and nutrition insights. The source cites InsideTracker, ZOE and Function Health as examples of that broader category.
That positioning matters because home testing by itself can be hard to differentiate when multiple companies can offer biomarker readouts. Adding structured follow-up guidance is a way to make the product more useful to consumers and potentially more commercially durable than a standalone test result. In that sense, the Thrive 5 launch is less about introducing a novel biomarker panel than about packaging common cardiometabolic measures with a behavior layer that aims to increase engagement after the test is complete.
